medline.ch Psychiatrie Schizophrenie und Psychosen

	Effects of Xanomeline and Trospium Chloride for Negative Symptoms Associated With Physical Activity in Younger and Older Adults with Schizophrenia: Results From a 52-Week, Open-label Clinical Trial. Schizophr Res Harvey PD, Kaul I, Chataverdi S, Patel T, Claxton A, Sauder C, Harvey CD, Brannan SK, Horan WP. PMID: 42019313 [PubMed - as supplied by publisher]
	Non-European migrants with schizophrenia spectrum disorders in Swiss forensic and general psychiatric care facilities - A comparative study using machine learning. Forensic Sci Int Hofmann AB, Dörner M, Stottmeister F, Machetanz L, Kirchebner J. PMID: 42019277 [PubMed - as supplied by publisher]
	Antipsychotic Efficacy and Safety of LB-102 in the Treatment of Adults With Acute Schizophrenia: A Randomized Clinical Trial. JAMA Psychiatry Eramo A, Correll CU, Walling DP, Kakar R, Bassani N, Callahan L, Lee BP, Prensky Z, Vaino AR, Kane JM. PMID: 42018313 [PubMed - as supplied by publisher]
	Effects of the Japanese Version of Metacognitive Training on Self-Efficacy and Sense of Coherence in Community-Dwelling Patients with Schizophrenia: A Pilot Study. Community Ment Health J Kuroda K, Hori T, Hayashi A. PMID: 42018101 [PubMed - as supplied by publisher]
	Associations Between PPAR-Î³ and Executive Function in Adolescents With Major Depressive Disorder With and Without Psychotic Features. Int J Dev Neurosci Karaca A, Band, Beyaz A, K, Ta, Turan S, Eray Çaml, Dirican M, Sürmen Gür E, Mutlu C. PMID: 42017904 [PubMed - indexed for MEDLINE]
	Stressful Life Events and Suicidality in First-Episode Psychosis. Clin Psychol Psychother Colomer-Salvans A, Serra-Arumí C, Vila-Badia R, Corbella-Sotil A, Abella M, Rubio-Abadal E, Leal-Pujol R, Dolz M, Bustos-Cardona T, Rolduà-Ros J, Del Cacho N, Butjosa A, PROFEP Group, Usall J. PMID: 42017601 [PubMed - indexed for MEDLINE]
	Associations Between Serum Adipokine, Antipsychotic Exposure, and Clinical Characteristics in Chronic Schizophrenia: A Cross-Sectional Study. Neuropsychopharmacol Rep Ohno Y, Saito K, Hanabusa K, Nakai A, Nagai T, Hida N, Sanada K. PMID: 42017366 [PubMed - indexed for MEDLINE]
	Pottery art therapy for chronic schizophrenia: Impact on negative symptoms, quality of life, and social skills in a randomized controlled trial. J Educ Health Promot Praveena R, Natarajan S, Mathangi DC, Thamilselvan P. PMID: 42016434 [PubMed]
	Schizophrenia and accelerated ageing: systematic review and future research directions. Br J Psychiatry Fernandez-Egea E, Garcia-Rizo C, Kirkpatrick B. PMID: 42015596 [PubMed - as supplied by publisher]
	Psychosocial Factors Affecting Community Integration in Schizophrenia Patients: The Moderating Role of Perceived Policy Effectiveness. Brain Behav Co, Yalç. PMID: 42015585 [PubMed - indexed for MEDLINE]
	Methylphenidate and Psychotic Symptoms in Children and Adolescents: A Disproportionality Analysis on the WHO Safety Database (VigiBase). J Child Adolesc Psychopharmacol Chrétien B, Blouet C, Alexandre J, Jardri R, Nishida K, Desaunay P, Guénolé F. PMID: 42015492 [PubMed - indexed for MEDLINE]
	Antipsychotic dose is not associated with cognitive function in patients with schizophrenia aged under 40: a cross-sectional observational study with retrospective dose estimation. BMC Psychiatry Özkalayc, Ta, Küçük E, Uysal F. PMID: 42015170 [PubMed - as supplied by publisher]
	Driver or passenger? A new assessment of genes in the schizophrenia-associated 3q29 deletion locus for contribution to neurodevelopmental disorders. J Neurodev Disord Herriges AR, Purcell RH. PMID: 42015005 [PubMed - as supplied by publisher]
	Multimodal microglial and kynurenine pathway alterations across the affective-psychosis spectrum: a systematic review of patterns, heterogeneity, and dimensional implications. Mol Psychiatry Nussbaumer M, Guest PC, Schiltz K, Dudeck L, Asl LS, Meyer-Lotz G, Dobrowolny H, Leucht S, Bernstein HG, Nickl-Jockschat T, Fernandes BS, Steiner J. PMID: 42014469 [PubMed - as supplied by publisher]
	Corrigendum to "Effect of computerized cognitive remediation therapy combined with individualized occupational therapy on cognitive function and functional outcomes in patients with schizophrenia: A randomized controlled trial" [Psychiatry Research 354 (2025) 116789]. Psychiatry Res Hu G, Wei D, Zhang J, Liu J, Liao L, Zheng L, Wu H, Wu X, Wei B, Wan J. PMID: 42014217 [PubMed - as supplied by publisher]
	MicroRNAs as potential biomarkers in schizophrenia: Current methodological limitations and challenges. Prog Neuropsychopharmacol Biol Psychiatry Hernaez M, Parellada E, Brunet M. PMID: 42013994 [PubMed - as supplied by publisher]
	From brain bioenergetics to hypothalamic glucoregulation: A shared-systems hypothesis for intrinsic dysglycemia in schizophrenia. Rev Endocr Metab Disord Hamel L, Pereira S, Yang Z, Garrido AN, Agarwal SM, Lam TKT, Hahn MK. PMID: 42012619 [PubMed - as supplied by publisher]
	Quality of Life in early-phase schizophrenia patients starting treatment with long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST). Eur Psychiatry Schulze AT, Tschiderer L, Post F, Frajo-Apor B, Fleischhacker W, Davidson M, Hofer A. PMID: 42011073 [PubMed - as supplied by publisher]
	A Multidisciplinary Child-Adult Psychiatry Model to Refine the Risk of Psychotic Transition in Clinical High Risk Adolescents: A Clinical Case Study. Clin Child Psychol Psychiatry Sibut R, Rhetore L, Besse J, Lachal J. PMID: 42011015 [PubMed - as supplied by publisher]
	Mental health help-seeking by US college students with a diagnosis of psychosis. Soc Psychiatry Psychiatr Epidemiol Godoy-Henderson C, Denner SS, Flesaker M, Weinberg J, Dalhoe M, Lipson SK. PMID: 42010171 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 68617

Seite 1 von 3431



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung